CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 期刊论文
2015, 卷号: 75
作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li
收藏  |  浏览/下载:59/0  |  提交时间:2020/01/04
A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 会议论文
CANCER RESEARCH, 2015-05-01
作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/04
Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文
CANCER RESEARCH, 2015-05-01
作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文
2015, 卷号: 4, 期号: 5, 页码: 557-573
作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 期刊论文
2015, 卷号: 75
作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace